25
Addressing Treatment Challenges in Cystic Fibrosis

Addressing Treatment Challenges in Cystic Fibrosis

Embed Size (px)

DESCRIPTION

Addressing Treatment Challenges in Cystic Fibrosis. Program Goals. Pseudomonas aeruginosa. Eradication of Mucoid Pseudomonas Infection EPIC Clinical Trial*. EPIC Results. Management of Exacerbations. Cystic Fibrosis Guidelines. Cystic Fibrosis Guidelines. - PowerPoint PPT Presentation

Citation preview

Page 1: Addressing Treatment Challenges in Cystic Fibrosis

Addressing Treatment Challenges in Cystic Fibrosis

Page 2: Addressing Treatment Challenges in Cystic Fibrosis
Page 3: Addressing Treatment Challenges in Cystic Fibrosis

Program Goals

Page 4: Addressing Treatment Challenges in Cystic Fibrosis

Pseudomonas aeruginosa

Page 5: Addressing Treatment Challenges in Cystic Fibrosis

Eradication of Mucoid Pseudomonas Infection

EPIC Clinical Trial*

Page 6: Addressing Treatment Challenges in Cystic Fibrosis

EPIC Results

Page 7: Addressing Treatment Challenges in Cystic Fibrosis

Management of Exacerbations

Page 8: Addressing Treatment Challenges in Cystic Fibrosis

Cystic Fibrosis Guidelines

Page 9: Addressing Treatment Challenges in Cystic Fibrosis

Cystic Fibrosis Guidelines

Page 10: Addressing Treatment Challenges in Cystic Fibrosis

Why Don’t Physicians FollowClinical Practice Guidelines?

Page 11: Addressing Treatment Challenges in Cystic Fibrosis

Personalized Medicine Targeting the CFTR

Page 12: Addressing Treatment Challenges in Cystic Fibrosis

Strategies for Modifying the Underlying Defect in CF

Page 13: Addressing Treatment Challenges in Cystic Fibrosis

Strategies for Modifying the Underlying Defect in CF (cont)

Page 14: Addressing Treatment Challenges in Cystic Fibrosis

Ivacaftor in Patients With CF and the G551D Mutation

Page 15: Addressing Treatment Challenges in Cystic Fibrosis
Page 16: Addressing Treatment Challenges in Cystic Fibrosis

F508 (F508del)

Page 17: Addressing Treatment Challenges in Cystic Fibrosis

Corrector TherapyPhase 2 Results of Lumacaftor + Ivacaftor

Page 18: Addressing Treatment Challenges in Cystic Fibrosis

Looking to the Future

Page 19: Addressing Treatment Challenges in Cystic Fibrosis

Will Improving CFTR Function Affect Chronic Pseudomonas

Infection?

Page 20: Addressing Treatment Challenges in Cystic Fibrosis

Practical Advice to Address the Challenges of Complex Medical

Regimens

Page 21: Addressing Treatment Challenges in Cystic Fibrosis

Abbreviations

Page 22: Addressing Treatment Challenges in Cystic Fibrosis

References

Page 23: Addressing Treatment Challenges in Cystic Fibrosis

References (cont)

Page 24: Addressing Treatment Challenges in Cystic Fibrosis

References (cont)

Page 25: Addressing Treatment Challenges in Cystic Fibrosis

References (cont)